Dr. Pryor is the Cheif Operating Officer at ZZ Biotech, the partnering company in NN104 RHAPSODY. Dr. Pryor joined the company full-time in 2010 to coordinate drug development operations including manufacturing, quality systems, regulatory affairs, and clinical research.
Previously, he served as Chief Operating Officer of SynthRx, Inc., Associate Director of Drug Development at Kémia, Inc., and Group Leader at Corvas International, Inc. Dr. Pryor has served on the Boards of Directors for multiple non-profit corporations and currently serves on the Advisory Board of Assay Depot.
Dr. Pryor received his BA in chemistry magna cum laude from Rice University, a PhD in organic chemistry from the Massachusetts Institute of Technology, and an MBA from the Rady School of Management at the University of California, San Diego.